Clinical Trials · NCT01794429
Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Bjorn H. Ebdrup
- Enrollment
- 45
- Start date
- Feb 2013
- Locations
- 1 site, Denmark
- Primary endpoint
- Weight loss